(Q39817495)

English

Norcantharidin induces cell cycle arrest and inhibits progression of human leukemic Jurkat T cells through mitogen-activated protein kinase-mediated regulation of interleukin-2 production

scientific article published on November 12, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Norcantharidin induces cell cycle arrest and inhibits progression of human leukemic Jurkat T cells through mitogen-activated protein kinase-mediated regulation of interleukin-2 production (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

based on heuristic

inferred from title

5

object named as

Cheng-Deng Kuo

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21075198

26 August 2024

author name string

Hui-Fen Liao

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Yu-Jen Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Chin-Hung Chou

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Fang-Wei Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21075198

26 August 2024

publication date

12 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0887233310002936?httpAccept=text/xml

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

https://api.elsevier.com/content/article/PII:S0887233310002936?httpAccept=text/plain

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Toxicology in Vitro

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

206-212

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells

1

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Norcantharidin-induced apoptosis is via the extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells

2

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Inhibitory effect of norcantharidin, a derivative compound from blister beetles, on tumor invasion and metastasis in CT26 colorectal adenocarcinoma cells

3

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells

4

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

A small-molecule metastasis inhibitor, norcantharidin, downregulates matrix metalloproteinase-9 expression by inhibiting Sp1 transcriptional activity in colorectal cancer cells

5

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Norcantharidin is a small-molecule synthetic compound with anti-angiogenesis effect

6

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT

7

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

MAP kinases in the immune response

8

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

New insights into the control of MAP kinase pathways

9

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells

10

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A

11

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Cyclosporine neurotoxicity: a review

12

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Complementary DNA for human T-cell cyclophilin.

13

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

From receptors to stress-activated MAP kinases

14

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Norcantharidin-induced post-G(2)/M apoptosis is dependent on wild-type p53 gene

15

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A.

16

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Suppressive effects of T-412, a flavone on interleukin-4 production in T cells

18

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

19

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

22 Isolation and characterization of bovine brain calcineurin: A calmodulin-stimulated protein phosphatase

20

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Comparisons of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytes

21

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio.

22

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Norcantharidin inhibits DNA replication and induces apoptosis with the cleavage of initiation protein Cdc6 in HL-60 cells

23

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Norcantharidin preferentially induces apoptosis in human leukemic Jurkat cells without affecting viability of normal blood mononuclear cells.

24

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

25

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells

26

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

In vitro assessment of renal toxicity and inflammatory events of two protein phosphatase inhibitors cantharidin and nor-cantharidin.

27

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.

28

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines

29

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Protein kinase Cbeta modulates ligand-induced cell surface death receptor accumulation: a mechanistic basis for enzastaurin-death ligand synergy.

30

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Vomitoxin-mediated IL-2, IL-4, and IL-5 superinduction in murine CD4+ T cells stimulated with phorbol ester calcium ionophore: relation to kinetics of proliferation

31

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand

32

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Caspase-3-Like Activity Is Necessary for IL-2 Release in Activated Jurkat T-cells

33

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases

35

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Prosurvival and proapoptotic functions of ERK1/2 activation in murine thymocytes in vitro.

36

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Medical uses of mylabris in ancient China and recent studies

38

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Inhibition of calcineurin by quercetin in vitro and in Jurkat cells

39

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Therapeutic potential of a synthetic peptide inhibitor of nuclear factor of activated T cells as antirestenotic agent.

40

1 reference

10.1016/J.TIV.2010.11.001

https://api.crossref.org/works/10.1016/J.TIV.2010.11.001

26 August 2024

Identifiers

10.1016/J.TIV.2010.11.001

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39817495&oldid=2236506308"